aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Illumina, Inc. is a leading American company based in San Diego, California, specializing in life science tools and integrated systems for genetic variation analysis. The company offers sequencing and array-based instruments, consumables, and whole-genome and targeted resequencing kits. It operates through Core Illumina and GRAIL segments, focusing on large-scale genetic analysis.
Illumina has significantly impacted genomics by providing advanced tools for genetic research and diagnostics. Its technologies are widely used in medical research, clinical applications, and biotechnology. The company's innovations have accelerated genomic discoveries and personalized medicine advancements.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Genetic Sequencing
Technology
Analytics, Biotech
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was Illumina Inc founded?
Illumina Inc was founded in 1998.
When was Illumina Inc’s last funding round?
Illumina Inc’s most recent funding round was for $750M (USD) in January 2023.
How many employees does Illumina Inc have?
Illumina Inc has 11500 employees as of Feb 6, 2024.
How much has Illumina Inc raised to-date?
As of July 05, 2023, Illumina Inc has raised a total of $778M (USD) since Jan 4, 2023.
Add Comparison
Total Raised to Date
$778M
USD
Last Update Jan 4, 2023
Last Deal Details
$750M
USD
Jan 4, 2023
Post Ipo Debt
Total Employees Over Time
11500
As of Feb 2024
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts